Virelix

Manufacturer
Oncora Pharma, LLC
Effective date
2026-09-10
Label type
DIETARY SUPPLEMENT
Version
4
Source
daily-update
Hydrated at
2026-09-12 01:01:50

Label at a glance#

ProductVirelix
Active ingredientASCORBIC ACID, CHOLECALCIFEROL, THIAMINE HYDROCHLORIDE, PYRIDOXINE HYDROCHLORIDE, FOLIC ACID, CYANOCOBALAMIN, NICOTINAMIDE ADENINE DINUCLEOTIDE, UBIQUINONE
Label structure7 sections

Dosage and administration

Adults: One tablet daily as a dietary supplement, preferably with a meal, or as recommended by a healthcare professional.

Label contents#

Full prescribing information#

Health Claim Section:

HEALTH CLAIM SECTION

Virelix Multivitamin

Dispensed by Prescription

Description:

STATEMENT OF IDENTITY SECTION

85477-533-30

Reserved for Professional Recommendation

Virelix Tablets should be administered under the supervision of a licensed medical practitioner.

Virelix Tablets are orally administered prescription dietary supplement tablets intended to provide significant amounts of Vitamins B1, B3, B6, B12, C, D3, folic acid, and NADH to supplement the diet and help assure that nutritional deficiencies of these vitamins will not develop.

This listed product is not a National Drug Code,but instead has merely been formatted to comply with standard industry practice for pharmacy and insurance computer systems.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

All prescriptions using this product shall be pursuant to state statutes as applicable. This is not an Orange Book product. This product may be administered only under a physician’s supervision. There are no implied or explicit claims on therapeutic equivalence.

Manufactured for:

Oncora Pharma

Dallas TX 75228

Warnings:

WARNINGS SECTION

This product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Virelix Tablets should only be used under the direction and supervision of a licensed medical practitioner. Use with caution in patients that may have a medical condition, are pregnant, lactating, trying to conceive, under the age of 18, or taking medications.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Dosage and Administration:

DOSAGE & ADMINISTRATION SECTION

Adults: One tablet daily as a dietary supplement, preferably with a meal, or as recommended by a healthcare professional.

Precautions:

PRECAUTIONS SECTION

CONTRAINDICATIONS

This product is contraindicated in patients with known hypersensitivity to any of the ingredients.

PRECAUTIONS

Use under the direction and supervision of a licensed healthcare professional.

ADVERSE REACTIONS

Allergic sensitization has been reported following oral administration of folic acid. Consult your physician immediately if adverse reactions occur.

KEEP OUT OF THE REACH OF CHILDREN.

Storage:

SAFE HANDLING WARNING SECTION

Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F).

Label:

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

pdp
pdp

Product Linked Resources#

Resource, Code type, Value table
ResourceCode typeValueEquivalent identifiersSource image
BarcodeEAN-130854770533301GTIN-13: 0854770533301
EAN-13: 0854770533301
GTIN-12: 854770533301
UPC-A: 854770533301
GTIN storage (14 digits): 00854770533301
virelix-1.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
cf050ccd-1144-f76a-e00d-e5698d8597d4Product name620250625
59361619-24d9-b610-eca6-5a7f25ed5e03Product name520240909
b82b4008-22fd-05f5-6cc6-c0a6e81c65b8Product name220240805
91c62db0-0295-c81c-d10a-0856c259edd6Product name220200428
d32bc2b8-0bb7-2216-87aa-24639646e202Product name320190619
c5cd4727-ac49-4409-82b1-5bd8006c3ec7Product name120171122
d206bb34-ea65-399d-70d9-834f22dc2c18Product name320170724
5e18e798-5614-cf5c-0185-38b1cb77a093Product name220160822
60c52429-fcef-eb54-2387-43bc9e4f296bProduct name120140508

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 16 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
85477-53385477-533-30

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 13 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
32026-05-07full-release2026-06-01 02:52:54

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Ascorbic acidASCORBIC ACIDZydus Pharmaceuticals USA Inc.f0b683f8-189b-4a3f-9ffe-f91df6d798b62026-09-03Warnings, Adverse reactionsName fallback
generic name: ASCORBIC ACID
Ascorbic acidASCORBIC ACIDZydus Lifesciences Limitedd2d29ffd-5483-45bb-9d1b-da7af23b37202026-09-03Name fallback
generic name: ASCORBIC ACID
Ascorbic AcidASCORBIC ACIDRenova Pharmaceuticals LLCa6481bae-2397-44c7-a51d-4f47ad91bd2c2026-08-19Warnings, Adverse reactionsName fallback
generic name: ASCORBIC ACID
AscorASCORBIC ACIDMcGuff Pharmaceuticals, Inc.388aad52-fc01-4784-9791-1dbc80c693062026-05-29Warnings, Adverse reactionsName fallback
generic name: ASCORBIC ACID
Ascorbic AcidASCORBIC ACIDFresenius Kabi USA, LLC1606e29f-0e80-4069-b688-daab9cbff20a2025-12-17Warnings, Adverse reactionsName fallback
generic name: ASCORBIC ACID
Skin Renewing SerumASCORBIC ACIDGuangzhou Danting Bath&Body Care Industry Co. Ltd396c2a8d-ac95-cbef-e063-6294a90aff392025-08-23WarningsName fallback
generic name: ASCORBIC ACID

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.